Unusual presentation of chromoblastomycosis due to Cladophialophora carrionii in a renal and pancreas transplant recipient patient successfully treated with posaconazole and surgical excision

Transplant Infectious Disease

Volumn 12, Issue 2, 2010, Pages 180-183

  Dupont, C ^a   Duong, T A ^a   Mallet, S ^a   Mamzer Bruneel, M F ^a   Thervet, E ^a   Bougnoux, M E ^a   Dupont, B ^a  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

Chromoblastomycosis; Cladophialophora carrionii; Posaconazole; Renal and pancreas transplant

Indexed keywords

AMPHOTERICIN B; AZATHIOPRINE; CASPOFUNGIN; FLUCONAZOLE; INTERNAL TRANSCRIBED SPACER; INTERNAL TRANSCRIBED SPACER 1; INTERNAL TRANSCRIBED SPACER 4; ITRACONAZOLE; POSACONAZOLE; PREDNISONE; RIBOSOME RNA; TACROLIMUS; UNCLASSIFIED DRUG; VORICONAZOLE;

ADULT; ANTIBIOTIC RESISTANCE; ARTICLE; CASE REPORT; CHROMOMYCOSIS; CLADOPHIALOPHORA CARRIONII; CLADOSPORIUM; CLINICAL EXAMINATION; DRUG BLOOD LEVEL; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; GRAFT RECIPIENT; GRAFT REJECTION; GRANULOMATOUS INFLAMMATION; HISTIOCYTE; HISTOPATHOLOGY; HUMAN; KIDNEY PANCREAS TRANSPLANTATION; MALE; MINIMUM INHIBITORY CONCENTRATION; NEUTROPHIL; NONHUMAN; NUCLEOTIDE SEQUENCE; PHAEOHYPHOMYCOSIS; PRIORITY JOURNAL; SKIN BIOPSY; SKIN SURGERY;

ANTIFUNGAL AGENTS; ASCOMYCOTA; CHROMOBLASTOMYCOSIS; HUMANS; IMMUNOCOMPROMISED HOST; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; PANCREAS TRANSPLANTATION; TREATMENT OUTCOME; TRIAZOLES;

EID: 77950569235     PISSN: 13982273     EISSN: 13993062     Source Type: Journal    
DOI: 10.1111/j.1399-3062.2009.00477.x     Document Type: Article

References (15)

1. Revankar SG. Dematiaceous fungi. Mycoses 2007 50 (2) : 91 101. (Pubitemid 46257147)
2. Nulens E, De Laere E, Vandevelde H, et al. Alternaria infectoria phaeohyphomycosis in a renal transplant patient. Med Mycol 2006 44 (4) : 379 382. (Pubitemid 43922075)
3. McGinnis MR. Chromoblastomycosis and phaeohyphomycosis: new concepts, diagnosis, and mycology. J Am Acad Dermatol 1983 8 (1) : 1 16.
4. Mouchalouat Mde F, Galhardo MC, Fialho PC, Coelho JM, Zancope-Oliveira RM, Valle AC. Cladophialophora carrionii: a rare agent of chromoblastomycosis in Rio de Janeiro State, Brazil. Rev Inst Med Trop Sao Paulo 2008 50 (6) : 351 353.
5. Ameen M, Arenas R. Developments in the management of mycetomas. Clin Exp Dermatol 2009 34 (1) : 1 7.
6. WhiteT, BurnsT, Lee S,TaylorT. Amplication and direct sequencing of fungal ribosomal RNA genes for phylogenetics. In: Innis DH, Sninsky JJ,WhiteTJ, eds. AGuide to Methods and Applications. San Diego: Academic Press, 1990: 315-322.
7. Minotto R, Bernardi CD, Mallmann LF, Edelweiss MI, Scroferneker ML. Chromoblastomycosis: a review of 100 cases in the state of Rio Grande do Sul, Brazil. J Am Acad Dermatol 2001 44 (4) : 585 592. (Pubitemid 32249512)
8. Pena-Penabad C, Duran MT, Yebra MT, Rodriguez-Lozano J, Vieira V, Fonseca E. Chromomycosis due to Exophiala jeanselmei in a renal transplant recipient. Eur J Dermatol 2003 13 (3) : 305 307. (Pubitemid 36683447)
9. Chowdhary A, Guarro J, Randhawa HS, et al. A rare case of chromoblastomycosis in a renal transplant recipient caused by a non-sporulating species of Rhytidhysteron. Med Mycol 2008 46 (2) : 163 166. (Pubitemid 351372335)
10. Franco A, Aranda I, Fernandez MJ, et al. Chromomycosis in a European renal transplant recipient. Nephrol Dial Transplant 1996 11 (4) : 715 716. (Pubitemid 26114562)
11. Morales LA, Gonzalez ZA, Santiago-Delpin EA. Chromoblastomycosis in a renal transplant patient. Nephron 1985 40 (2) : 238 240.
12. Wackym PA, Gray GF Jr., Richie RE, Gregg CR. Cutaneous chromomycosis in renal transplant recipients. Successful management in two cases. Arch Intern Med 1985 145 (6) : 1036 1037.
13. Kwon Chung KJ, Bennett E. Medical Mycology. London: Febiger, 1992
14. Queiroz-Telles F, Esterre P, Perez-Blanco M, Vitale RG, Salgado CG, Bonifaz A. Chromoblastomycosis: an overview of clinical manifestations, diagnosis and treatment. Med Mycol 2009 47 (1) : 3 15.
15. Langner S, Staber PB, Neumeister P. Posaconazole in the management of refractory invasive fungal infections. Ther Clin Risk Manag 2008 4 (4) : 747 758.